Market Tracker

04/28 5:16pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

4.25
Delayed Data
As of Apr 28
 -0.01 / -0.23%
Today’s Change
3.49
Today|||52-Week Range
10.98
-1.39%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.26
Today’s open4.28
Day’s range4.20 - 4.28
Volume95,300
Average volume (3 months)248,127
Market cap$209.7M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+61.02%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc-0.10-2.22%
AVXLAnavex Life Sciences...-0.04-0.71%
ARWRArrowhead Pharmaceut...-0.01-0.64%
BCLIBrainstorm Cell Ther...-0.05-1.20%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts